4 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Long-Term Follow-up of Patients With Alcoholic Liver Cirrhosis Treated With Cellgram-LCChemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, liver disorder, substance-related disorderRecruitingNot stated2026-09-21NCT05093881
Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic CirrhosisChemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, liver disorder, substance-related disorderRecruitingPhase 32026-09-21NCT04689152
Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Chronic Total OcclusionsChronic Total Occlusion of Coronary ArteryRecruitingNot stated2026-06-25NCT03667196
Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)Nutritional and Metabolic Diseases, glucose intolerance, glucose metabolism disease, hyperglycemia, metabolic diseaseEnrolling by invitationPhase 42026-01-07NCT05579626